Bone density loss from Anastrozole partially reverses after treatment stops
Better post-surgery care would dramatically improve cancer survival
21 January 2021New combination of immunotherapies shows great promise for treating lung cancer
22 January 2021Bone density loss from Anastrozole partially reverses after treatment stops
A study by researchers from Queen Mary University of London shows that bone loss known to be associated with the use of the breast cancer prevention drug Anastrozole partially reverses, particularly at the lumbar spine, after stopping treatment.
